Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) EPS (Basic) (2024 - 2025)

Historic EPS (Basic) for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $0.41.

  • Neuphoria Therapeutics' EPS (Basic) rose 13333.33% to $0.41 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.24, marking a year-over-year decrease of 8730.07%. This contributed to the annual value of -$4.09 for FY2025, which is 7801.66% up from last year.
  • Neuphoria Therapeutics' EPS (Basic) amounted to $0.41 in Q4 2025, which was up 13333.33% from -$4.41 recorded in Q3 2025.
  • Over the past 5 years, Neuphoria Therapeutics' EPS (Basic) peaked at $6.55 during Q1 2025, and registered a low of -$9.34 during Q2 2025.